A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
On collagen, ageing and surgical treatment options following commercial kit withdrawals - a critical analysis
The banning of all mesh for prolapse by the FDA has failed to recognize that there is a major difference between mesh sheets applied behind the vagina for POP and repair of POP by shortening and reinforcing damaged suspensory ligaments, much as is used in the midurethral sling (MUS) which retains endorsement by the FDA. Mesh sheets interfere with the vaginal elasticity essential for function and may cause pain and massive urine loss postoperatively, in some cases; tapes far less so, as theydoi:10.34057/ppj.2019.38.02.007 fatcat:chaoqqkmkfhf7i2hl2ylfo2wmu